Maternal coronary heart disease and mortality following hypertensive disorders of pregnancy and/or diabetes
Authors:
Open Access
- 11 July 2025
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 24 (1) , 1-12
Abstract
Background: Pre-pregnancy hypertension (HTN), hypertensive disorders of pregnancy (HDP), and diabetes have been linked to increased risk of post-pregnancy coronary heart disease (CHD) and all-cause mortality, but few studies have investigated their cumulative impact. This study aimed to assess the potential relationship between pre-pregnancy HTN, HDP, and diabetes and their cumulative impact on maternal cardiovascular outcomes defined as incident CHD and all-cause mortality within 5 years of delivery and over the entire study period (up to 14 years after delivery). Methods: This retrospective cohort study included 430,545 women aged 12–49 with ≥ 1 singleton, live birth in South Carolina (2004–2016) including non-Hispanic White (NHW; 59.2%), non-Hispanic Black (NHB; 31.4%), and Hispanic (9.4%) women. Birth certificate and hospitalization/emergency department (ED) visit data defined pre-pregnancy HTN, HDP (preeclampsia, eclampsia, gestational HTN), and diabetes (pre-pregnancy, gestational). Hospitalization/ED visit and death certificate data defined incident CHD and all-cause mortality. Covariate-adjusted Cox proportional hazard models were used to assess associations between CHD and mortality by exposure. Results: After adjustment for covariates relative to women without any of the three conditions (diabetes, pre-pregnancy HTN, HDP), incident CHD risk was increased within 5 years of delivery for women with diabetes (HR = 1.57; 95% CI 1.28–1.92), HDP (HR = 1.85; 95% CI 1.60–2.15), HDP and diabetes (HR = 2.29; 95% CI 1.73–3.03), HDP and pre-pregnancy HTN (HR = 3.13; 95% CI 2.66–3.68), and all three conditions (HR = 4.87; 95% CI 3.95–6.01). All-cause mortality risk was increased for diabetes (HR = 1.34; 95% CI 1.01–1.78), HDP and pre-pregnancy HTN (HR = 1.53; 95% CI 1.15–2.03), and all three conditions (HR = 2.25; 95% CI 1.51–3.36), but not HDP or HDP and diabetes. Conclusions: Within 5 years of delivery, incident CHD and all-cause mortality rates were highest for women with two or three conditions, specifically HDP, diabetes, and/or pre-pregnancy HTN, with all rates higher for NHB than NHW women. Thus, it is critical to implement clinical prevention strategies to improve risk factor screening and identification among women of child-bearing age.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01HL163963, R01HL163963, R01HL163963, R01HL163963)
This publication has 28 references indexed in Scilit:
- Association of Hypertensive Disorders of Pregnancy With Future Cardiovascular DiseaseJAMA Network Open, 2023
- Hypertensive disorders of pregnancy and long‐term cardiovascular health: FIGO Best Practice AdviceInternational Journal of Gynecology & Obstetrics, 2023
- Association of Concomitant Gestational Hypertensive Disorders and Gestational Diabetes With Cardiovascular DiseaseJAMA Network Open, 2022
- Assessment of the Validity of Administrative Data for Gestational Diabetes AscertainmentAmerican Journal of Obstetrics & Gynecology MFM, 2022
- A global view of hypertensive disorders and diabetes mellitus during pregnancyNature Reviews Endocrinology, 2022
- Risk of future cardiovascular diseases in different years postpartum after hypertensive disorders of pregnancy: A systematic review and meta-analysisMedicine, 2022
- Trends in Gestational Diabetes at First Live Birth by Race and Ethnicity in the US, 2011-2019JAMA, 2021
- Integrative analysis of Mendelian randomization and Bayesian colocalization highlights four genes with putative BMI-mediated causal pathways to diabetesScientific Reports, 2020
- Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysisDiabetologia, 2019
- Hypertension Complicating Diabetic Pregnancies: Pathophysiology, Management, and ControversiesThe Journal of Clinical Hypertension, 2011